Concepedia

Effect of CFTR modulator therapy on cystic fibrosis-related diabetes

Holly Gaines, Kellie Jones, Jonea Lim, Nighat F. Medhi, Sixia Chen, R. Hal Scofield

Journal of Diabetes and its Complications · 2021 · 50 citations · 19 references

DOIFull text

Open access

Concepts

References

19

A CFTR Potentiator in Patients with Cystic Fibrosis and the <i>G551D</i> Mutation

Bonnie W. Ramsey, Jane C. Davies, Noel G. McElvaney et al. · New England Journal of Medicine · 2011 · 2.2K citations · Full text

, , +8

Clinical Care Guidelines for Cystic Fibrosis–Related Diabetes

Antoinette Moran, Carol Brunzell, Richard Cohen et al. · Diabetes Care · 2010 · 716 citations · Full text

, , +17

Cystic Fibrosis–Related Diabetes: Current Trends in Prevalence, Incidence, and Mortality

Antoinette Moran, Jordan Dunitz, Brandon M. Nathan et al. · Diabetes Care · 2009 · 645 citations · Full text

, , +14

Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Potentiator VX-770 (Ivacaftor) Opens the Defective Channel Gate of Mutant CFTR in a Phosphorylation-dependent but ATP-independent Manner

Paul D. W. Eckford, Canhui Li, Mohabir Ramjeesingh et al. · Journal of Biological Chemistry · 2012 · 308 citations · Full text

, , +17

Future trends in cystic fibrosis demography in 34 European countries

Pierre‐Régis Burgel, Hanne Vebert Olesen, Laura Viviani et al. · European Respiratory Journal · 2015 · 277 citations · Full text

, , +17